Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02576990
Brief Title: Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)

First Submitted : October 14, 2015
First Submitted that Met QC Criteria : October 14, 2015
First Posted : October 15, 2015 (Estimate)

Results First Submitted : May 26, 2020
Results First Submitted that Met QC Criteria : June 11, 2020
Results First Posted : June 24, 2020

Last Update Submitted that Met QC Criteria : June 11, 2020
Last Update Posted : June 24, 2020